ATS 2024 Final Program

Click on the session title to view the speakers

209

MONDAY • MAY 20

3:51 Impact of Positive Airway Pressure (PAP)-Therapy on Hospitalization in Obstructive Sleep Apnea (OSA): Analysis of a German Healthcare Database 4:03 Do Endotypes Predict Symptom-Based Phenotypes?

609 Barriers to Optimizing Comorbid COPD and Cardiovascular Disease Management Among Socially Disadvantaged Patients: Clinician Perspectives 610 Beyond Physical Frailty - The Impact of Social Frailty on Survival and Hospitalizations in COPD 611 Association of Guideline Alignment and Medication Concordance With Medication Usage in COPD 612 Optimizing COPD Self-management Treatment Using the Multiphase Optimization Strategy: Results From a Pilot Factorial Experiment 613 Causes of 30-day Readmission Following Against Medical Advice Discharge After Acute Exacerbation of Chronic Obstructive Pulmonary Disease 614 Geographic and Payer Variation in the Prevalence, Demographics, and COPD-related Hospital Utilization of Patients With COPD 615 Readmissions Decreased Following Implementation of a COPD Bundled Payments for Care Innovation Program: An Instrumental Variable Analysis 616 Developing and Validating a COPD-Specific 30-day Readmission Risk Prediction Tool 617 Training and Validation of a COPD-Specific 90-day Readmission Risk Prediction Tool Using Multi-Center Data 618 Perceived Need by Patients for Care, Access to Care, and the Decision to Seek Care for Chronic Obstructive Pulmonary Disease Exacerbations 619 A Comparison of Claims-based and Self-reported Supplemental Oxygen Use in Older Adults With Chronic Obstructive Pulmonary Disease in a Nationally-representative Study 620 Home Pulse Oximetry and Triage of Patients With Chronic Lung Disease: A Retrospective Study 621 Spirometry Parameter Prediction Using Acoustic Characteristics of Cough 622 Food Insecurity Is Associated With Lung Function and Symptom Burden 623 Beginning Varenicline in Patients With Chronic Obstructive Pulmonary Disease and Serious Mental Illness Is Efficacious and Well Tolerated!

BEHAVIORAL • CLINICAL POSTER DISCUSSION SESSION

B101 COPD EPIDEMIOLOGY, DISPARITIES, AND HEALTH SERVICES RESEARCH 2:15 p.m. - 4:15 p.m. San Diego Convention Center Room 5A-B (Upper Level) Poster Viewing 2:15-3:00 Discussion 3:00-4:15 601 Better Together: An AI-Driven, Software-Based, Respiratory Therapist-Administered Home COPD Management Program Reduces Hospitalizations by 65% in a Home Ventilation Population 602 A Digital Quality Improvement Program Delivered by Clinical Pharmacists Can Reduce Acute Care Visits in COPD 603 Behavioral Regulation, Basic Psychological Needs in Exercise, and Self-efficacy in Individuals Experiencing an Exacerbation of Chronic Obstructive Pulmonary Disease: Preliminary Analysis of a Cross-sectional Study 604 Behavioral Change Intervention Based on 605 Long-Term Outcomes Associated With the Super-Exacerbator Phenotype in COPD 606 Association of Income With Long-term Survival Following Hospitalization for Chronic Obstructive Lung Disease 607 Association Between Delay in Treatment for COPD Exacerbations and Duration of Symptoms 608 Characterizing Tobacco Use Status Among a National Cohort of Veterans With COPD Self-determination Theory on Physical Activity After COPD Exacerbation: Preliminary Analysis of a Randomized Controlled Trial

ATS 2024 Conference Program • San Diego, CA